共 50 条
- [1] Improvement in overall blood glucose control with insulin glargine plus insulin lispro in comparison with NPH insulin plus unmodified human insulin in people with Type 1 diabetes.[J]. DIABETOLOGIA, 2003, 46 : A271 - A271Ashwell, SAmiel, SBilous, RHeller, SHepburn, DHome, P
- [2] Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes[J]. DIABETES CARE, 2008, 31 (06) : 1112 - 1117Ashwell, Simon G.Bradley, ClareStephens, James W.Witthaus, ElkeHome, Philip D.
- [3] Quality of life is improved with insulin glargine plus lispro compared with NPH insulin plus regular human insulin in patients with Type 1 diabetes[J]. DIABETOLOGIA, 2004, 47 : A306 - A306Witthaus, EJohnston, PBradley, C
- [4] A randomized crossover trial comparing insulin glargine plus insulin lispro with NPH insulin plus soluable insulin in adolescents with Type 1 diabetes.[J]. DIABETOLOGIA, 2002, 45 : A281 - A281Murphy, NKeane, SOng, KFord-Adams, MEdge, JDunger, D
- [5] Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens[J]. DIABETES CARE, 2003, 26 (03) : 799 - 804Murphy, NPKeane, SMOng, KKFord-Adams, MEdge, JAAcerini, CLDunger, DB
- [6] A Randomized cross-over trial comparing insulin glargine plus lispro with NPH insulin plus soluble insulin in adolescents with type 1 diabetes[J]. DIABETES, 2002, 51 : A54 - A54Murphy, NPKeane, SMOng, KKFord-Adams, MEEdge, JADunger, DB
- [7] Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 79 - 86Sargin, HSargin, MAltuntas, YSengül, AMOrbay, ESeber, SUçak, SYayla, A
- [8] A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes[J]. DIABETES CARE, 2000, 23 (11) : 1666 - 1671Raskin, PKlaff, LBergenstal, RHallé, JPDonley, DMecca, T
- [9] Insulin glargine versus NPH insulin in patients with type 1 diabetes[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876Ratner, R
- [10] Is hypoglycaemia an increasing barrier to achieving HbA1c target for NPH insulin than insulin glargine?[J]. DIABETOLOGIA, 2014, 57 : S262 - S263Zhang, Q.Chou, E.Chung, H-W.Wang, H.